Literature DB >> 1622947

Management of traumatic optic neuropathy--a study of 23 patients.

J A Mauriello1, J DeLuca, A Krieger, M Schulder, L Frohman.   

Abstract

Twenty three patients with traumatic optic neuropathy were managed by medical and surgical treatment as follows. High dose intravenous steroids were initiated in all patients. If visions did not improve significantly after 24 to 48 hours decompression of an optic nerve sheath haematoma by medial orbitotomy and neurosurgical decompression of the optic canal were considered based on computed tomographic scan findings. Nine of 16 patients who received steroids only showed significant improvement. One of three showed improvement on optic nerve decompression after steroid failure; three or four showed improvement on optic nerve decompression after steroid failure; three or four showed improvement with combined optic nerve sheath decompression by the medial orbitotomy and decompression of the optic canal by frontal craniotomy. A lucid interval of vision after injury and an enlarged optic nerve sheath were associated with an improved prognosis. Five of the 23 patients had a lucid interval and all five had a final improved vision, while only five of 18 patients without a lucid interval improved. Similarly seven of the nine with an enlarged optic nerve sheath showed improvement while only three of 10 patients (three bilateral cases) who presented with no light perception improved with medical and surgical treatment. While a prospective controlled study of the management of traumatic optic neuropathy is necessary this preliminary study suggests that treatment of traumatic optic nerve sheath haematoma by optic nerve sheath decompression should be considered in selected patients.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1622947      PMCID: PMC504284          DOI: 10.1136/bjo.76.6.349

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  15 in total

1.  The management of traumatic optic neuropathy.

Authors:  N R Miller
Journal:  Arch Ophthalmol       Date:  1990-08

2.  Transantral-ethmoidal decompression of optic canal fracture.

Authors:  J S Kennerdell; G A Amsbaugh; E N Myers
Journal:  Arch Ophthalmol       Date:  1976-06

3.  Modified optic nerve sheath decompression provides long-term visual improvement for pseudotumor cerebri.

Authors:  R C Sergott; P J Savino; T M Bosley
Journal:  Arch Ophthalmol       Date:  1988-10

4.  Decompression of the optic nerve in the optic canal. A transorbital approach.

Authors:  N B Call
Journal:  Ophthalmic Plast Reconstr Surg       Date:  1986       Impact factor: 1.746

5.  Microscopic intranasal decompression of the optic nerve.

Authors:  M Takahashi; M Itoh; M Kaneko; J Ishii; A Yoshida
Journal:  Arch Otorhinolaryngol       Date:  1989

6.  Extracranial optic nerve decompression for traumatic optic neuropathy.

Authors:  M P Joseph; S Lessell; J Rizzo; K J Momose
Journal:  Arch Ophthalmol       Date:  1990-08

7.  Surgical treatment of progressive visual loss in traumatic optic neuropathy. Report of two cases.

Authors:  J Guy; M Sherwood; A L Day
Journal:  J Neurosurg       Date:  1989-05       Impact factor: 5.115

8.  Spontaneous visual recovery from traumatic optic neuropathy after blunt head injury.

Authors:  M J Wolin; P J Lavin
Journal:  Am J Ophthalmol       Date:  1990-04-15       Impact factor: 5.258

9.  Results of optic nerve sheath fenestration for pseudotumor cerebri. The lateral orbitotomy approach.

Authors:  J J Corbett; J A Nerad; D T Tse; R L Anderson
Journal:  Arch Ophthalmol       Date:  1988-10

10.  Indirect optic nerve trauma.

Authors:  S Lessell
Journal:  Arch Ophthalmol       Date:  1989-03
View more
  9 in total

1.  Treatment selections of 239 patients with blepharospasm and Meige syndrome over 11 years.

Authors:  J A Mauriello; S Dhillon; T Leone; B Pakeman; R Mostafavi; M C Yepez
Journal:  Br J Ophthalmol       Date:  1996-12       Impact factor: 4.638

2.  High-dose intravenous methylprednisolone in recent traumatic optic neuropathy; a randomized double-masked placebo-controlled clinical trial.

Authors:  Morteza Entezari; Zhaleh Rajavi; Neda Sedighi; Narssis Daftarian; Masoumeh Sanagoo
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-01-31       Impact factor: 3.117

3.  Traumatic Optic Neuropathy.

Authors:  Neil R Miller
Journal:  J Neurol Surg B Skull Base       Date:  2021-02-02

Review 4.  Traumatic optic neuropathy: a review of current studies.

Authors:  Bin Chen; Hengsen Zhang; Qing Zhai; Huaipeng Li; Chunxia Wang; Yong Wang
Journal:  Neurosurg Rev       Date:  2022-01-16       Impact factor: 3.042

Review 5.  An evolving perspective of endoscopic transnasal optic canal decompression for traumatic optic neuropathy in clinic.

Authors:  Jingquan Lin; Wanglu Hu; Qun Wu; Jianmin Zhang; Wei Yan
Journal:  Neurosurg Rev       Date:  2019-11-22       Impact factor: 3.042

6.  Role of the maxillofacial surgeon in the management of severe ocular injuries after maxillofacial fractures.

Authors:  Fabio Roccia; Paolo Boffano; Valeria Guglielmi; Paolo Forni; Emanuele Cassarino; Juri Nadalin; Antonio Fea; Giovanni Gerbino
Journal:  J Emerg Trauma Shock       Date:  2011-04

Review 7.  Controversies in neuro-ophthalmology: steroid therapy for traumatic optic neuropathy.

Authors:  Rohit Saxena; Digvijay Singh; Vimla Menon
Journal:  Indian J Ophthalmol       Date:  2014-10       Impact factor: 1.848

Review 8.  A Systematic Literature Review on Traumatic Optic Neuropathy.

Authors:  Saeed Karimi; Amir Arabi; Iman Ansari; Toktam Shahraki; Sare Safi
Journal:  J Ophthalmol       Date:  2021-02-26       Impact factor: 1.909

Review 9.  Surgery for traumatic optic neuropathy.

Authors:  Patrick Yu-Wai-Man; Philip G Griffiths
Journal:  Cochrane Database Syst Rev       Date:  2013-06-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.